Use of Keraton and Vita-Pos drugs at the stages of treatment of patients with occupational chemical damage to the visual organ
Abstract
Purpose of the study. To study the effectiveness of the drug Keraton and VitA-Pos at the stages of treatment of patients with occupational chemical damage to the organ of vision.
Materials and methods of research: included: clinical examination of the cornea, fluorescein staining, determination of the corneal lesion index, photographing the anterior part of the eyes.
Clinical studies were conducted in 21 (28 eyes) patients with burn eye disease. The comparative dynamics of complications of eye burn disease during traditional and combined treatment using keratoprotectors and immunostimulants (Keraton and VitA-POS) in the clinic was studied.
Research results and discussion. All 21 patients (28 eyes) were divided into 2 groups. In the main group, treatment was carried out in 11 (17 eyes) patients with the keratoprotector Keraton, which was instilled 1 drop 4 times a day and the immunostimulant VitA-POS at night before bedtime. In the control group, 10 (11 eyes) patients were treated with dexpanthenol gel 5% 2 times a day until complete epithelialization.
According to the outcome, healing without scars within 7-10 days was observed in 11 (52.38%) patients, healing almost without scars, epithelization not only from the periphery, but also due to processes in - 5 (23.81%), inevitable rough scar healing with slow epithelization only from the edges in 3 (14.29%), tissue defects and cicatricial deformities were noted in 2 (9.52%) patients.
Conclusions. 1. The use of the drug Keraton and VitA-POS showed its effectiveness and good tolerability in all patients who suffered occupational injuries.
2. The use of combination therapy with PERG led to more structured and anatomically correct healing of the cornea in 80% of patients than treatment with an alternative drug in the control group.
About the Authors
L. M. MaksudovaUzbekistan
Lailo M. Maksudova – Doctor of Medical Sciences, Associate Professor of the Department of Ophthalmology of the Center for the Development of Professional Qualifications of Medical Workers of the Republic of Uzbekistan.
Tel.: (+998) 93 595 00 55
Sh. B. Inagamdzhanova
Uzbekistan
D. M. Babakhanova
Uzbekistan
References
1. Камилов Х.М., Максудова Л.М. «Национальный журнал глаукома» Россия, 2017, Т. 16, № 2, стр. 69-73
2. Максудова Л.М. «Основы деструктивных и репаративных процессов химических ожогов глаз в реалиях и перспективах» // Монография, Ташкент, 2023, 181 стр.
3. Канюков В.Н., Стадников А.А., Трубина О.М., Яхина О.М. Аппликация биопластического материала «Гиаматрикс» при заболеваниях роговицы // Вестник ОГУ. - 2013. - № 4. - С. 243-235.
4. Майчук Д.Ю. Рецидивирующие эрозии роговицы: особенности возникновения и лечения // Новое в офтальмологии. – 2014. - № 3. – С. 72-75
5. Bron A., Burgess S. Inherited recurrent corneal erosion // Trans. Ophthalmol. Soc. UK. – 1981. – Vol. 101. – P. 239-43.
6. Chandler P. Recurrent erosion of the cornea // Am. J. Ophthalmol. – 1945. – Vol. 28. – P. 355-363.
7. Chandler P. Recurrent erosion of the cornea // Trans. Am. Ophthalmol. Soc. – 1944. – Vol. 42. – P. 355-7.
8. Diez-Feijóo E., Grau A., Abusleme E., Duran J. Clinical Presentation and Causes of Recurrent Corneal Erosion Syndrome: Review of 100 Patients // Cornea. – 2014. – Vol. 33 – P. 571-5.
9. Gifford S. Epithelial dystrophy and recurrent erosion of the cornea as seen with the slit-lamp // Arch. Ophthalmol. – 1925. – Vol. 54. – P. 217-232.
10. Goldman J., Dohlman C., Kravitt B. The basement membrane of the human cornea in recurrent epithelial erosion syndrome // Trans. Am. Acad. Ophthalmol. Otolaryngol. – 1969. – Vol. 73(3). – P. 471-81.
11. Hope-Ross M. et al. Recurrent corneal erosion: clinical features // Eye (Lond.). – 1994. – Vol. 8. – P. 373-377.
Review
For citations:
Maksudova L.M., Inagamdzhanova Sh.B., Babakhanova D.M. Use of Keraton and Vita-Pos drugs at the stages of treatment of patients with occupational chemical damage to the visual organ. Herald of the medical and social institute of Tajikistan. 2023;(4):16-20. (In Russ.)




